Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
7 cm above the ulnar styloid processes
A systematic review and meta-analysis published in 2020 found that liraglutide treatment resulted in significant reductions in body weight (mean difference approximately 4-5 kg compared to placebo or metformin), improved insulin sensitivity markers, and favourable changes in lipid profiles
Changes in ammonia, albumin, total carnitine, free carnitine, acyl carnitine, taurine, Tyrosine, AST, and alanine aminotransferase (ALT) levels, PT, fasting blood sugar level (FBS), BCAA/L-tyrosine molar ratio (BTR), Fischer ratio, and Child-Pugh scores after the 3-month treatment were analyzed using the Wilcoxon signed-ranks test and Mann-Whitney U test or two-way repeated-measures analysis of variance
Phase 3 data shows up to 71.2 pounds at 68 weeks
Non-GLP-1 weight-loss medication plans start at $196/month
US$ 20.75
US$ 26.02
US$ 23.55
US$ 26.76
US$ 28.03
US$ 27.02
US$ 22.88
US$ 25.29
US$ 21.63
US$ 26.17
US$ 20.63
US$ 23.08
US$ 27.65
US$ 23.00
US$ 27.87
